59572-711 : Reblozyl 25 mg Subcutaneous Injection, Powder, Lyophilized, for Solution


NDC59572-711
Labeler: Celgene
Product Type: Human Prescription Drug
Drug Name:  Reblozyl
Dosage Form: Subcutaneous Injection, Powder, Lyophilized, for Solution
Application #: BLA761136
Rev. Date: 


NDC Package Codes:

  • 59572-711-01: 1 VIAL, GLASS IN 1 CARTON (59572‑711‑01) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION IN 1 VIAL, GLASS

Active Ingredients:

  • Luspatercept

Dosage Strength:

  • 25 mg

Related Products:

Based on records with the same trade name.
  • 59572-775 Reblozyl 75 mg Subcutaneous Injection, Powder, Lyophilized, for Solution by Celgene

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 59572-711 QR Code

< Prev: 59572-710Next: 59572-720 >




Notice: The MedsChat® NDC Database compiles publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.


Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 8 February 2020.

We are committed to your privacy.

Copyright © 2005-2021 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA